Healthcare Leaders Utilize Newswire’s EMA GT Market Builder to Increase Engagement and Brand Awareness

NEW YORK, NY / ACCESSWIRE / October 20, 2020 / ​​Healthcare institutions have faced a variety of challenges as a result of the ongoing COVID-19 pandemic. From outbreaks, to PPE shortages, to transmission risks, and overcrowded facilities, it is fair to say that the current global crisis has exposed major issues with the American healthcare system. As individual institutions and healthcare companies introduce new technologies and solutions to adapt with the times, Newswire’s Earned Media Advantage Guided Tour Market Builder presents key opportunities to generate greater brand awareness, community engagement and reach a wider customer base for increased sales opportunities.

In a report by Biometric Update, editor Sarah Amundsson cited a study by Grand View Research that showed the expected increase in demand for biometrics in healthcare. Biometrics is one of many healthcare trends that has become a major talking point, largely due to the growth in information exchange within the industry. According to the report, biometrics is expected to increase to $14.5 billion by 2025. Similar trends include the growing demand for telehealth technology and efficient IT systems that can automate tedious tasks and minimize strenuous workloads for healthcare professionals.

“We have had many clients that have responded to the challenges in the healthcare industry with major technological innovations. Others have altered operational procedures to solve unique problems within their niche. In both cases, there is a newsworthy angle that exists that can be leveraged within the Market Builder program to increase brand recognition and awareness,” said Anthony Santiago, Newswire’s VP of Marketing.

Newswire provides the only integrated media and marketing communications utility that converts your owned media into earned media opportunities to accelerate business growth. Through targeted content distribution and effective outreach, Newswire’s team is able to increase consumer interest in its customers across all industries.

“The program is powered by the efforts of our Earned Media Advantage Strategists,” said Charlie Terenzio, Newswire’s VP Earned Media Advantage Business. “The strategists work hand-in-hand with customers and in-house teams to identify key opportunities and manage the overall media and marketing communications strategies.”

Newswire’s EMA GT Market Builder has propelled medical, healthcare, and fitness companies into the spotlight of their respective industry media, which has resulted in both elevated levels of brand awareness and web traffic.

Find out how Newswire’s Earned Media Advantage Guided Tour Market Builder can elevate your brand today.

About Newswire​

Newswire delivers press release and multimedia distribution software and services (SaaS) that empower the Earned Media Advantage: greater brand awareness, increased traffic, greater return on media and marketing communications spend and the competitive edge. With over a decade of experience, Newswire continues to provide its customers with the ability to deliver the right message to the right audience at the right time through the right medium.​

To learn more about how Newswire can help you, visit http://www.newswire.com.

Contact Information

Charlie Terenzio
VP of Earned Media Advantage Business
Newswire
Office: 813-480-3766
Email: charlie@newswire.com​​

Related Images

SOURCE: Newswire

View source version on accesswire.com:
https://www.accesswire.com/611215/Healthcare-Leaders-Utilize-Newswires-EMA-GT-Market-Builder-to-Increase-Engagement-and-Brand-Awareness

Staff

Recent Posts

TestoPrime Review: Why TestoPrime Is Better Than Other Testosterone Booster Supplement in 2025?

TestoPrime is a top rated, all natural testosterone booster for men in their 40's and…

1 hour ago

Lipozem Reviews: Does It Really Work For Weight Loss in 2025?

Lipozem: We Tested Lipozem Supplement - Here Is Our Honest Review NEW YORK CITY, NY…

1 hour ago

Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid’s Emerging Role in Renal Replacement Therapy Decisions

Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal…

1 hour ago

Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates

Ad hoc announcement pursuant to Art. 53 LR Revenue Growth: Full-year 2024 revenue of €265.7…

5 hours ago

RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months

BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has…

7 hours ago